Saint Joseph Hospital - Orange

Summary

Saint Joseph Hospital - Orange is a medical facility located in Orange, California. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Saint Joseph Hospital - Orange is involved with conducting 160 clinical trials across 296 conditions. There are 15 research doctors associated with this hospital, such as Timothy E. Byun, Bhavraj S Khalsa, MD, Robert B. Ash, and Brian Kolski, MD.

Top PIs

Clinical Trials running at Saint Joseph Hospital - Orange

Breast Cancer

Ovarian Cancer

Pancreatic Cancer

Pancreatic Carcinoma

Cancer

Lung Cancer

Endometrial Cancer

Uterine Cancer

Breast cancer

Non-Small Cell Lung Cancer

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.

Recruiting

2 awards

Phase 3

19 criteria

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.

Recruiting

2 awards

Phase 3

19 criteria

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Recruiting

2 awards

Phase 3

13 criteria